Published in Ann Oncol on March 15, 2007
Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res (2008) 2.94
Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer (2008) 1.23
Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer (2010) 1.05
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian J Palliat Care (2012) 0.85
Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer (2012) 0.85
Physical activity level and quality of life in long term lung cancer survivors. Lung Cancer (2012) 0.84
Quality of life of patients with lung cancer. Onco Targets Ther (2016) 0.81
Changes in quality of life and its related factors in liver cancer patients receiving stereotactic radiation therapy. Support Care Cancer (2008) 0.81
Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study. Oncologist (2012) 0.80
Fatigue as a Driver of Overall Quality of Life in Cancer Patients. PLoS One (2015) 0.76
The effect of group mindfulness - based stress reduction program and conscious yoga on the fatigue severity and global and specific life quality in women with breast cancer. Med J Islam Repub Iran (2015) 0.76
Acupuncture for cancer-related fatigue in lung cancer patients: a randomized, double blind, placebo-controlled pilot trial. Support Care Cancer (2017) 0.75
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J (2009) 3.08
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 2.31
Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys (2001) 2.14
Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol (2005) 1.96
Prevalence and correlates of fear of falling, and associated avoidance of activity in the general population of community-living older people. Age Ageing (2007) 1.93
Methods for the quantification of DNA double-strand breaks determined from the distribution of DNA fragment sizes measured by pulsed-field gel electrophoresis. Radiat Res (1995) 1.61
Camurati-Engelmann disease: a late and sporadic case with metaphyseal involvement. Eur Radiol (1999) 1.61
Reliability of molecular weight determination of proteins by polyacrylamide gradient gel electrophoresis in the presence of sodium dodecyl sulfate. Anal Biochem (1978) 1.57
Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys (1994) 1.51
Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate? Radiother Oncol (1997) 1.46
Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study. AIDS (1991) 1.46
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.46
Hypoxia as a target for combined modality treatments. Eur J Cancer (2002) 1.24
Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat Res (1996) 1.19
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer (2006) 1.19
Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev (2005) 1.17
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types. Br J Cancer (2008) 1.15
A systematic review of Internet-based supportive interventions for caregivers of patients with dementia. Int J Geriatr Psychiatry (2013) 1.14
Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum. Cancer Gene Ther (2001) 1.12
Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells. Int J Radiat Biol (1997) 1.11
Low control beliefs, classical coronary risk factors, and socio-economic differences in heart disease in older persons. Soc Sci Med (2005) 1.11
Selective serum IgA deficiency. Frequency among 15,200 French blood donors. Vox Sang (1973) 1.10
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Ann Oncol (2008) 1.08
[The German version of the Falls Efficacy Scale-International Version (FES-I)]. Z Gerontol Geriatr (2006) 1.08
Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy. Med Phys (2010) 1.06
Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Gene Ther (2001) 1.05
Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas. FEMS Immunol Med Microbiol (2001) 1.04
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas. Eur J Cancer (2000) 1.04
Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors. Vox Sang (1972) 1.04
The relative contribution of domains of quality of life to overall quality of life for different chronic diseases. Qual Life Res (2004) 1.04
Purification of the human serum inter-alpha-trypsin inhibitor by zinc chelate and hydrophobic interaction chromatographies. Anal Biochem (1980) 1.02
Tumor-specific gene delivery using genetically engineered bacteria. Curr Gene Ther (2003) 1.00
Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol (1999) 0.99
Molecular weight estimation of proteins by electrophoresis in linear polyacrylamide gradient gels in the absence of denaturing agents. Anal Biochem (1979) 0.98
A new method for determination of molecular weights of proteins by electrophoresis across a sodium dodecyl sulfate (SDS)-polyacrylamide gradient gel. Anal Biochem (1976) 0.98
Human monoclonal antibody against Rh(D) antigen: partial characterization of the Rh(D) polypeptide from human erythrocytes. Blood (1987) 0.97
Gender-specific changes in quality of life following cardiovascular disease: a prospective study. J Clin Epidemiol (2002) 0.97
Phased attenuation correction in respiration correlated computed tomography/positron emitted tomography. Med Phys (2006) 0.96
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol (2007) 0.96
Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol (1993) 0.95
Monoclonal gammopathies in asymptomatic HIV-seropositive patients. Clin Chem (1987) 0.93
Patients' self-report and family caregivers' perception of quality of life in patients with advanced cancer: how do they compare? Eur J Cancer Care (Engl) (2006) 0.93
Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha. Appl Environ Microbiol (1999) 0.92
Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas. Hematol Oncol (1994) 0.92
Effects and feasibility of a standardised orientation and mobility training in using an identification cane for older adults with low vision: design of a randomised controlled trial. BMC Health Serv Res (2009) 0.92
Flow cytometric monitoring of allergen induced basophil activation. Cytometry (1995) 0.91
Oxygenation of head and neck tumors. Cancer (1993) 0.90
Independent and functional validation of a multi-tumour-type proliferation signature. Br J Cancer (2012) 0.90
Efficient isolation of total RNA from Clostridium without DNA contamination. J Microbiol Methods (2001) 0.90
Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenström's macroglobulinemia. Acta Med Scand (1982) 0.90
Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours. Br J Cancer (2003) 0.90
The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancer. Radiat Res (2001) 0.90
Heterotaxy syndrome in an adult, with polysplenia, visceral and cardiovascular malposition. JBR-BTR (2001) 0.89
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer (2000) 0.89
Flow cytometric evaluation of human basophils. Cytometry (1993) 0.89
Validation of the Care-Related Quality of Life Instrument in different study settings: findings from The Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS-MDS). Qual Life Res (2014) 0.89
A global calibration model for a-Si EPIDs used for transit dosimetry. Med Phys (2007) 0.88
Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang (1984) 0.87
Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. Radiother Oncol (1997) 0.87
Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters. Anticancer Res (2001) 0.87
Evaluating an intervention to reduce fear of falling and associated activity restriction in elderly persons: design of a randomised controlled trial [ISRCTN43792817]. BMC Public Health (2005) 0.87
Therapy response assessment in radiotherapy of lung cancer. Q J Nucl Med Mol Imaging (2011) 0.86
Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters. Appl Environ Microbiol (2001) 0.86
Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol (1993) 0.85
Purification and partial characterization of a hepatocyte antiproliferative glycopeptide. J Cell Biochem (1989) 0.85
Systematic survey of monoclonal gammapathies in the sera from blood donors. Transfusion (1979) 0.85
In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment. Int J Radiat Oncol Biol Phys (2001) 0.84
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Commun (2001) 0.84
The extracellular domain of the human erythropoietin receptor: expression as a fusion protein in Escherichia coli, purification, and biological properties. Prep Biochem Biotechnol (1999) 0.84
Isotypic analysis of grass pollen-specific immunoglobulins in human plasma. 1. Specialization of certain classes and subclasses in the immune response. Int Arch Allergy Immunol (1993) 0.84
Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetry. Med Phys (2009) 0.83
Clostridium spores for tumor-specific drug delivery. Anticancer Drugs (2002) 0.83
Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS (1988) 0.83
Verification of treatment parameter transfer by means of electronic portal dosimetry. Med Phys (2004) 0.83
Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies. Int Arch Allergy Immunol (1993) 0.82
Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors. Lancet (1986) 0.82
Serum neopterin and beta 2-microglobulin concentrations in monoclonal gammopathies. Acta Med Scand (1988) 0.82
Follow-up of monoclonal gammopathies in asymptomatic HIV-infected subjects. Clin Chem (1989) 0.82
Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer. Strahlenther Onkol (2011) 0.82
BOLD contrast fMRI of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5 T. Eur Radiol (2001) 0.82
Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol (1998) 0.81
Monoclonal IgD. A comparative study of 60 sera with IgD "M" component. Biomedicine (1974) 0.81
Relocatable fixation systems in intracranial stereotactic radiotherapy. Accuracy of serial CT scans and patient acceptance in a randomized design. Strahlenther Onkol (2011) 0.81
Local production of IgG and IgG subclasses in the aqueous humor of patients with Fuchs heterochromic cyclitis, herpetic uveitis and toxoplasmic chorioretinitis. Int Ophthalmol (1998) 0.81
Disablement process and the utilization of home care among non-institutionalized elderly people: contrasting results between cross-sectional and panel data. Disabil Rehabil (2003) 0.81
[The psychometric properties of three self-report screening instruments for identifying frail older people in the community]. Tijdschr Gerontol Geriatr (2011) 0.81
Measuring rebelliousness and predicting health behaviour and outcomes: an investigation of the construct validity of the Social Reactivity Scale. J Health Psychol (2009) 0.81
Rapid progression to AIDS in dual HIV-1/HTLV-I infection. Lancet (1990) 0.81
Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. FASEB J (1998) 0.81
Waldenström's macroglobulinemia in monozygotic twins. Acta Med Scand (1986) 0.80
Selective alterations of the antibody response to HIV-1. Appl Biochem Biotechnol (1998) 0.80
Preparation and biological properties of monoclonal antibodies against human erythropoietin. Hybridoma (1993) 0.80
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor? Strahlenther Onkol (2012) 0.80
Sedimentation rate as a predictive marker in HIV infection. AIDS (1988) 0.80
Adaptive response and induced resistance. C R Acad Sci III (1999) 0.80
IgG monoclonal gammapathy in the sister of a patient with Waldenström's macroglobulinaemia. Biomedicine (1973) 0.80
[Studies on human alpha-2 macroglobulin structure and its complexes with proteases, using polyacrylamide gel electrophoresis]. Rev Fr Transfus Immunohematol (1975) 0.80
Measurement of alloantibody by flow cytometry. J Immunol Methods (1990) 0.80